Hi all,
Long time reader, first time poster.
I have loved reading through all the insights provided on this thread and appreciate the role it has played in my research.
There has been a lot of talk around the markets ADN can enter once production has started. However, I was just wondering if someone could provide some clarity around ADN's financing needs to get them through to production? How much additional cash will they need and how will they access this cash? Debt? A cap raise?
Any insight is greatly appreciated. Thanks team - GLTAH!
- Forums
- ASX - By Stock
- ADN
- General comments/chat
General comments/chat, page-13357
-
- There are more pages in this discussion • 31,563 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADN (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.57M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.6¢ | $19.77K | 3.041M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 19595227 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 7890877 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 19595227 | 0.006 |
44 | 28815157 | 0.005 |
12 | 11398750 | 0.004 |
8 | 13134995 | 0.003 |
7 | 15650497 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 7890877 | 23 |
0.008 | 8368677 | 19 |
0.009 | 14861776 | 19 |
0.010 | 4800882 | 8 |
0.011 | 27266522 | 7 |
Last trade - 15.59pm 13/11/2024 (20 minute delay) ? |
Featured News
ADN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online